miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients

BACKGROUND: The microRNA-205 (miR-205) has been shown to be deregulated in prostate cancer (PCa). Here we continue to investigate the prognostic and therapeutic potential of this microRNA. METHODS: The expression of miR-205 is measured by qRT–PCR and in situ hybridisation in a well-documented PCa co...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagman, Z, Haflidadóttir, B S, Ceder, J A, Larne, O, Bjartell, A, Lilja, H, Edsjö, A, Ceder, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668465/
https://www.ncbi.nlm.nih.gov/pubmed/23571738
http://dx.doi.org/10.1038/bjc.2013.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668465/
https://www.ncbi.nlm.nih.gov/pubmed/23571738
http://dx.doi.org/10.1038/bjc.2013.131

Ejemplares similares